What is Dilip Shanghvi's Net Worth?
Dilip Shanghvi is an Indian pharmaceutical entrepreneur who has a net worth of $20 billion. Dilip Shanghvi is the founder and managing director of Sun Pharmaceutical Industries Limited. Ever since its creation in 1982, Sun Pharma has developed into the fifth-largest drug-maker in India. However, he saw his fortune swell when the company's shares managed to gain 40% in 12 months. Thanks to his BA degree from the University of Calcutta and his extensive experience in the pharmaceutical industry, Shanghvi succeeded to build India's most valuable drug-producer in less than three decades. Furthermore, he is the Chairman of Sun Pharma`s primary American subsidiary, Caraco, which concluded $230 million acquisition of Nasdaq-listed skincare firm DUSA Pharmaceuticals and inked a deal to buy a US generics business of Japan's Takeda Pharmaceuticals for an undisclosed sum. As for his private life, he is married with two children.
Net Worth details: Dilip Shanghvi owns 54 percent of Sun Pharmaceutical Industries which includes his family's shares since he is the founder and managing director of the specialty generic drug maker. Shanghvi also owns 67 percent of Sun Pharma Advanced Research and 14 percent of drug and medical technology company BioLight Life Sciences. He owns 20 percent of Suzion Energy which he paid $289 million for, and 3 percent of Natco Pharma.
